ME02674B - Terapeutske upotrebe 1-[2-(2,4-dimetil-fenilsulfanil)fenil]piperazina - Google Patents
Terapeutske upotrebe 1-[2-(2,4-dimetil-fenilsulfanil)fenil]piperazinaInfo
- Publication number
- ME02674B ME02674B MEP-2017-94A MEP9417A ME02674B ME 02674 B ME02674 B ME 02674B ME P9417 A MEP9417 A ME P9417A ME 02674 B ME02674 B ME 02674B
- Authority
- ME
- Montenegro
- Prior art keywords
- phenylsulfanyl
- piperazine
- dimethyl
- phenyl
- therapeutic uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37588510P | 2010-08-23 | 2010-08-23 | |
| DKPA201000739 | 2010-08-23 | ||
| EP11749331.2A EP2608789B2 (en) | 2010-08-23 | 2011-08-22 | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine |
| PCT/DK2011/050317 WO2012025123A1 (en) | 2010-08-23 | 2011-08-22 | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02674B true ME02674B (me) | 2017-06-20 |
Family
ID=44532506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2017-94A ME02674B (me) | 2010-08-23 | 2011-08-22 | Terapeutske upotrebe 1-[2-(2,4-dimetil-fenilsulfanil)fenil]piperazina |
Country Status (30)
| Country | Link |
|---|---|
| US (5) | US20130184291A1 (me) |
| EP (1) | EP2608789B2 (me) |
| JP (1) | JP5902169B2 (me) |
| KR (1) | KR101816953B1 (me) |
| CN (1) | CN103068389A (me) |
| AP (1) | AP3583A (me) |
| AR (1) | AR082501A1 (me) |
| AU (1) | AU2011295465B8 (me) |
| BR (2) | BR112013002194A2 (me) |
| CA (1) | CA2807062C (me) |
| CL (1) | CL2013000492A1 (me) |
| CO (1) | CO6680652A2 (me) |
| CY (1) | CY1118886T1 (me) |
| DK (1) | DK2608789T3 (me) |
| ES (1) | ES2625142T3 (me) |
| HR (1) | HRP20170608T1 (me) |
| HU (1) | HUE034155T2 (me) |
| IL (1) | IL224371A (me) |
| LT (1) | LT2608789T (me) |
| ME (1) | ME02674B (me) |
| MX (1) | MX349724B (me) |
| PL (1) | PL2608789T3 (me) |
| PT (1) | PT2608789T (me) |
| RS (1) | RS55851B1 (me) |
| RU (1) | RU2564666C2 (me) |
| SG (1) | SG187649A1 (me) |
| SI (1) | SI2608789T1 (me) |
| TW (1) | TW201212918A (me) |
| WO (1) | WO2012025123A1 (me) |
| ZA (1) | ZA201301385B (me) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9822086B2 (en) | 2014-01-31 | 2017-11-21 | Egis Gyogyszergyar Zrt. | Process for the preparation of vortioxetine salts |
| CN104119298B (zh) * | 2014-08-13 | 2016-08-24 | 北京蓝贝望生物医药科技股份有限公司 | 氢溴酸沃赛汀或氢溴酸沃替西汀 |
| CN104119299B (zh) * | 2014-08-13 | 2016-08-17 | 北京蓝贝望生物医药科技股份有限公司 | 沃赛汀或沃替西汀的氢溴酸盐 |
| CN104610195B (zh) * | 2015-01-30 | 2017-06-27 | 上虞京新药业有限公司 | 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途 |
| KR20190025556A (ko) | 2016-07-01 | 2019-03-11 | 하. 룬드벡 아크티에셀스카브 | 항우울 효과의 신속한 개시를 위한 보티옥세틴 투여 요법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| EP0543584B1 (en) * | 1991-11-18 | 1996-05-22 | Lilly Industries Limited | Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system |
| US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
| US7159383B2 (en) | 2000-10-02 | 2007-01-09 | Rohr, Inc. | Apparatus, method and system for gas turbine engine noise reduction |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| BR122020011899B1 (pt) * | 2006-06-16 | 2021-05-11 | H. Lundbeck A/S | processos para a preparação de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina e para a fabricação do sal de adição de ácido bromídrico correspondente |
| TW200848411A (en) | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
-
2011
- 2011-08-17 TW TW100129338A patent/TW201212918A/zh unknown
- 2011-08-19 AR ARP110103029A patent/AR082501A1/es not_active Application Discontinuation
- 2011-08-22 JP JP2013525143A patent/JP5902169B2/ja active Active
- 2011-08-22 KR KR1020137004481A patent/KR101816953B1/ko active IP Right Grant
- 2011-08-22 BR BR112013002194A patent/BR112013002194A2/pt not_active Application Discontinuation
- 2011-08-22 PL PL11749331T patent/PL2608789T3/pl unknown
- 2011-08-22 HU HUE11749331A patent/HUE034155T2/en unknown
- 2011-08-22 US US13/812,073 patent/US20130184291A1/en not_active Abandoned
- 2011-08-22 ES ES11749331.2T patent/ES2625142T3/es active Active
- 2011-08-22 AU AU2011295465A patent/AU2011295465B8/en active Active
- 2011-08-22 LT LTEP11749331.2T patent/LT2608789T/lt unknown
- 2011-08-22 CA CA2807062A patent/CA2807062C/en active Active
- 2011-08-22 WO PCT/DK2011/050317 patent/WO2012025123A1/en active Application Filing
- 2011-08-22 CN CN2011800406861A patent/CN103068389A/zh active Pending
- 2011-08-22 AP AP2013006768A patent/AP3583A/xx active
- 2011-08-22 SI SI201131177A patent/SI2608789T1/sl unknown
- 2011-08-22 BR BR122020025600A patent/BR122020025600A2/pt not_active Application Discontinuation
- 2011-08-22 RS RS20170404A patent/RS55851B1/sr unknown
- 2011-08-22 ME MEP-2017-94A patent/ME02674B/me unknown
- 2011-08-22 PT PT117493312T patent/PT2608789T/pt unknown
- 2011-08-22 RU RU2013112890/15A patent/RU2564666C2/ru active
- 2011-08-22 DK DK11749331.2T patent/DK2608789T3/en active
- 2011-08-22 SG SG2013007380A patent/SG187649A1/en unknown
- 2011-08-22 EP EP11749331.2A patent/EP2608789B2/en active Active
- 2011-08-22 MX MX2013001570A patent/MX349724B/es active IP Right Grant
-
2013
- 2013-01-23 IL IL224371A patent/IL224371A/en active IP Right Grant
- 2013-02-20 CL CL2013000492A patent/CL2013000492A1/es unknown
- 2013-02-21 CO CO13035030A patent/CO6680652A2/es unknown
- 2013-02-22 ZA ZA2013/01385A patent/ZA201301385B/en unknown
-
2017
- 2017-04-18 HR HRP20170608TT patent/HRP20170608T1/hr unknown
- 2017-05-10 CY CY20171100501T patent/CY1118886T1/el unknown
-
2018
- 2018-09-07 US US16/124,497 patent/US20190000836A1/en not_active Abandoned
-
2020
- 2020-05-18 US US16/877,108 patent/US20210085674A1/en not_active Abandoned
-
2022
- 2022-01-07 US US17/570,998 patent/US20220370439A1/en not_active Abandoned
-
2023
- 2023-10-10 US US18/483,780 patent/US20240293397A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1165955A1 (en) | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine 1-[2-(24-)] | |
| IL246600B (en) | Heterocyclic compounds and their use | |
| ZA201107731B (en) | Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine | |
| CO7000771A2 (es) | Proceso para la fabricación de 1-[2-(2,4-dimetilsulfanil)fenil]piperazina | |
| PL2521450T3 (pl) | Grzybobójcze związki heterocykliczne | |
| IL225770A0 (en) | Heterocyclic compounds | |
| EP2637669A4 (en) | Heterocyclic compounds and their use | |
| EP2575462A4 (en) | Heterocyclic compounds and their use | |
| EP2643000A4 (en) | THERAPEUTIC PIPERAZINES | |
| HRP20130819T1 (en) | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine | |
| AP2013006987A0 (en) | Heterocyclic compounds suitable for the treatment of dyslipidemia | |
| IL223721A0 (en) | Heterocyclic compounds, their preparation and their therapeutic application | |
| AP3583A (en) | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine | |
| IL213917A0 (en) | Novel compounds for medical use as peptidase effectors | |
| HK1178529A1 (en) | Piperazines as antimalarial agents | |
| GB201019043D0 (en) | Use of 2',5'-oligoadenylate derivative compounds | |
| PL393335A1 (pl) | Nowe E-1,2-bis{4-[(2-(1-oxo-alkilo)-3-oxo-alkilo]fenylo) eteny oraz sposób ich otrzymywania | |
| GB201021416D0 (en) | Novel heterocyclic compounds | |
| GB201009514D0 (en) | Novel heterocyclic compounds | |
| GB201102024D0 (en) | Novel heterocyclic compounds 3 | |
| GB201101823D0 (en) | Novel heterocyclic compounds 4 | |
| GB201101822D0 (en) | Novel heterocyclic compounds 2 | |
| GB201101821D0 (en) | Novel heterocyclic compounds 1 |